Analyst firms · BofA Securities · ILMN
BofA Securities ILMN price target and rating history
Illumina Inc. (ILMN) · Health Care
BofA Securities rates Illumina Inc. (ILMN) Underperform with a $100 price target, as of its latest action on Dec 12, 2023. It has published 3 rating actions on ILMN since January 2022, including 2 upgrades and 1 downgrade. Across 5 firms with a ILMN price target in the last 12 months, the median target is $185.
- Current rating
- Underperform
- Price target
- $100
- Median target, all firms
- $185
- Actions on ILMN
- 3
BofA Securities price target on ILMN
Every BofA Securities rating on ILMN
- Dec 12, 2023
- Jan 7, 2022
- Jan 7, 2022
How other firms rate ILMN
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Stephens | Equal-Weight | $275 | Oct 23, 2026 |
| UBS | Buy | $260 | Sep 9, 2026 |
| Bernstein | Mkt Perform | $185 | Jun 26, 2026 |
| RBC Capital Markets | Outperform | $170 | May 15, 2026 |
| Daiwa | Outperform | $155 | May 14, 2026 |
Questions about BofA Securities and ILMN
- What is BofA Securities's price target for ILMN?
- BofA Securities's latest stated price target for Illumina Inc. (ILMN) is $100, from its action on Dec 12, 2023.
- What is BofA Securities's rating on ILMN?
- BofA Securities rates ILMN Underperform, a bearish rating, as of Dec 12, 2023.
- When did BofA Securities last change its view on ILMN?
- On Dec 12, 2023, BofA Securities downgrades to Underperform from Neutral, price target $140 to $100.
- How does BofA Securities's ILMN target compare with other analysts?
- Across 5 firms with a ILMN price target in the last 12 months, the median target is $185.
More ILMN rating histories
All BofA Securities ratingsILMN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.